Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume Publish Ahead of Print, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-07-02
DOI
10.14309/ajg.0000000000001347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Rohit Loomba et al. GASTROENTEROLOGY
- Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis
- (2020) Eduardo Vilar-Gomez et al. Clinical Gastroenterology and Hepatology
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
- (2020) Md. Mohaimenul Islam et al. Cancers
- Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
- (2020) Antonio Facciorusso et al. Cancers
- Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms
- (2019) Gyuri Kim et al. SEMINARS IN LIVER DISEASE
- Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
- (2019) Myriam Alexander et al. BMC Medicine
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Diabetes is Associated with Increased Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
- (2019) Ju Dong Yang et al. HEPATOLOGY
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- (2019) Tracey G. Simon et al. ANNALS OF INTERNAL MEDICINE
- Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Margarita N. German et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study
- (2018) Alina M. Allen et al. HEPATOLOGY
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
- (2016) Yao-Yao Zhou et al. Oncotarget
- Gender Differences in Adipocyte Metabolism and Liver Cancer Progression
- (2016) Otto K.-W. Cheung et al. Frontiers in Genetics
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Chemopreventive strategies in hepatocellular carcinoma
- (2013) Siddharth Singh et al. Nature Reviews Gastroenterology & Hepatology
- Statins and primary liver cancer
- (2012) Danitza Pradelli et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Estrogen Represses Hepatocellular Carcinoma (HCC) Growth via Inhibiting Alternative Activation of Tumor-associated Macrophages (TAMs)
- (2012) Weiwei Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
- (2012) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
- (2011) Neeraj Bhala et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started